|
BEG
BEG
Beige Holdings Limited - Appointment of new directors to the board
BEIGE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
(Registration number 1997/006871/06)
("Beige" or "the company")
ISIN Code: ZAE 000034161 Share code: BEG
APPOINTMENT OF NEW DIRECTORS TO THE BOARD
In compliance with paragraph 3.59 of the Listings Requirements of the JSE
Limited, the board of directors of Beige are pleased to announce, following
the approval of shareholders at the general meeting held on Monday, 13
November 2006, the appointments of Mr Yaseen Bhayat and Mr Ian Black as non
executive directors of the company, with immediate effect.
Yaseen is a chartered accountant and has an MBA from UCT. He has been a
member of the Thebe Group for the past 10 years and is a founder shareholder
of Thebe Medicare (Pty) Ltd ("Thebe Medicare"). He has significant experience
in the Health Care and Corporate Investment sectors and is responsible for all
healthcare (supply of products and services) strategic initiatives for Thebe
Investment Corporation (Pty) Limited. Yaseen is the CEO of Thebe Medicare and
serves on the board of directors of Thebe Investment Corporation (Pty) Limited
and Care Cross Health (Pty) Limited ("Care Cross Health").
Ian qualified with an M.Inst. Dirs, DMS. He is a seasoned international
businessman with 30 years experience in the healthcare and pharmaceutical
industry and is recognised as an international expert in the pharma industry.
Ian was the founder and chairman of Trinity Pharmaceuticals and has previously
held the positions of chairman of Viatris, Germany, deputy chairman of Norton
Pharmaceuticals, Regional director for Abbott Labs, Europe and Chief Executive
Officer of Consumer Products Bayer UK. He is currently the chairman of both
Care Cross Health and Thebe Medicare
In accordance with AltX Listings Requirements, shareholders are advised of the
risks of investing in a company listed on the AltX and that the JSE does not
guarantee the viability or the success of a company listed on the AltX. In
terms of the JSE Listings Requirements, a Designated Advisor has to be
retained by the company. The Designated Advisor is required, inter alia, to
attend all board meetings held by the company to ensure that all the JSE
Listings Requirements and applicable regulations are complied with, approve
the financial director of the company and guide the company in a competent,
professional and impartial manner. If the company fails to retain a
Designated Advisor it must make arrangements to appoint a new Designated
Advisor within 10 business days, failing which the company faces suspension of
trading of its securities. If a Designated Advisor is not appointed within 30
days of its suspension, the company faces the termination of its listing
without an offer to minorities.
Johannesburg
14 November 2006
Designated Advisor
Arcay Moela Sponsors (Pty) Ltd
Date: 14/11/2006 12:07:04 PM Produced by the JSE SENS Department
| Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information. | |||||||||||||
| Other Profile Group sites: FundsData Online (unit trust data) | Profile Group corporate site | |||||||||||||
| [ Terms of Use | Privacy Policy | PAIA manual | FAQs/Help | Site Map | © Copyright Reserved 2026 ] | |||||||||||||
|
|||||||||||||
